Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on Pharmacokinetics of DA-8010 in Healthy Subjects
NCT04686825Phase 1Completed
- Sponsor
- Dong-A ST
- Start
- Jan 2021
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of velufenacin in overactive bladder (OAB) (4 arms), sponsored by Dong-A ST. Primary endpoints: Peak Plasma Concentration and Area under the plasma concentration versus time curve. Started Jan 2021; status: completed.
02
Drugs
velufenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT04686825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04686825.